|
Menu d'accès rapide :
version française
|
Search :
Refuse, Resist, Cure : Donate all year long
Site map :
Notre sommaire :
News
Research
AFM's missions
AFM Congresses
More information for...
- Researchers
- Journalists
- Donations
- About this website
Votre navigation :
Home
Site map
Site map
News
More news
Press releases
Other sites
Research
Strategy
A general strategy
Presentation
Research programmes
Financial commitments 2007
Scientific Council
Further basic research
Through the development of Myology
Stem cells
Interactions within the muscle cell
Rare Diseases
Therapeutics
Evaluate emerging leads
The means at our disposal
Research centres of excellence
Généthon
Institut de Myologie
I-Stem
Other centres
International collaborations
Collaborations
Calls for proposals
Vector production centres
Clinical trials
Assistance in congresses
Results
Focus on the results in 2007
Focus 2006
Major breakthroughs achieved
Focus on the exon skipping
Therapeutic tracks
Presentation
Pharmacological treatments
Gene therapy
Cell therapy/Stem cells
Cell therapy
Stem cells
Others tracks
Clinical trials
What is a clinical trial ?
Understanding
From molecule to drugs
Guarantee of optimal safety
The status of orphan medicinal products
Clinical trials supported by AFM
How ?
Ongoing or future trials financed by the AFM
How can a patient participate ?
Neuromuscular diseases
Calls for proposals and fellowships
Objectives
Free standardised batches of myoblasts available
2008 Call for proposals
SMA Europe : Joint call for projects 2008
Results of previous Calls
AFM's missions
Our missions
Strategy
A global strategy
AFM's values
Patients involved at different levels of the Association
Helping patients
Strategy
Our campaigns and legislative actions
Key figures
Curing Diseases
Strategy
Research actions
Key figures
Communicating
Raise awareness, question and report
Key figures
Our organisation
Statutes
The Board of Directors
Consultative Bodies
Our partners
Généthon